Insulin Resistance and Substrate Metabolism After Acute Erythropoietin (EPO) Administration

NCT00793767 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Insulin Sensitivity

Interventions

DRUG: erythropoietin
DRUG: placebo (saline)

Sponsor

Aarhus University Hospital